Transdermal delivery system of hormones without penetration enhancers

Details for Australian Patent Application No. 2004298930 (hide)

Owner Bayer Schering Pharma Aktiengesellschaft

Inventors Langguth, Thomas; Dittgen, Michael; Huber, Petra; Bracht, Stefan; Schenk, Dirk

Agent Davies Collison Cave

Pub. Number AU-B-2004298930

PCT Pub. Number WO2005/058287

Priority 03078881.4 12.12.03 EP; 60/528,718 12.12.03 US

Filing date 10 December 2004

Wipo publication date 30 June 2005

Acceptance publication date 26 November 2009

International Classifications

A61K 9/70 (2006.01) Medicinal preparations characterised by special physical form - Web, sheet or filament bases

A61K 31/56 (2006.01) - Compounds containing cyclopenta[a]hydrophenanthrene ring systems

A61K 31/565 (2006.01) - not substituted in position 17 beta by a carbon atom, e.g. oestrane, oestradiol

A61P 15/18 (2006.01) Drugs for genital or sexual disorders

Event Publications

6 July 2006 PCT application entered the National Phase

  PCT publication WO2005/058287 Priority application(s): WO2005/058287

1 October 2009 Alteration of Name

  The name of the applicant has been altered to Bayer Schering Pharma Aktiengesellschaft 2005

26 November 2009 Application Accepted

  Published as AU-B-2004298930

25 March 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004298951-Bactericide against streptococcus mutans and streptococcus sobrinus

2004298911-Novel pharmaceutical compositions with increased activity